The effect of a repeated immunoadsorption in patients with dilated cardiomyopathy after recurrence of severe heart failure symptoms

Journal of Clinical Apheresis

Volumn 30, Issue 4, 2015, Pages 217-223

  Reinthaler, Markus ^a   Empen, Klaus ^a   Herda, Lars R ^a   Schwabe, Anna ^a   Rühl, Michael ^a   Dörr, Marcus ^a   Felix, Stefan B ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

Author keywords

dilated cardiomyopathy; heart failure; repeated immunoadsorption

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITOXIN; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; IMMUNOGLOBULIN G;

ADULT; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DETERIORATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMMUNOADSORPTION; MALE; MEDICAL DEVICE; NEW YORK HEART ASSOCIATION CLASS; RECURRENT DISEASE; RELAPSE; RETROSPECTIVE STUDY; SYMPTOM; AGED; BIOPSY; CARDIOMYOPATHY, DILATED; CHEMISTRY; COMPLICATION; ECHOCARDIOGRAPHY; ERGOMETRY; EXERCISE TEST; HEART FUNCTION TEST; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEMODYNAMICS; IMMUNOLOGY; MIDDLE AGED; SPIROMETRY; TIME FACTOR;

AGED; BIOPSY; CARDIOMYOPATHY, DILATED; ECHOCARDIOGRAPHY; ERGOMETRY; EXERCISE TEST; FEMALE; HEART FAILURE; HEART FUNCTION TESTS; HEMODYNAMICS; HUMANS; IMMUNOGLOBULIN G; IMMUNOSORBENT TECHNIQUES; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; SPIROMETRY; STROKE VOLUME; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 84939438871     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.21364     Document Type: Article

References (28)

1. McMurray JV, Adamopoulos S, Anker SD, Angelo Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Angel Gomez-Sanchez M, Jaarsma T, Køber L, Lip GH, Pietro Maggion A, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A,. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012; 33: 1787-1847.
2. McMurray JJ, Ostergren J, Swedberg K, Granger CB, Held P, Michelson EL, Olofsson B, Yusuf S, Pfeffer MA,; CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin converting-enzyme inhibitors: the CHARM-Added trial. Lancet 2003; 362: 767-771.
3. Nohria A, Lewis E, Stevenson LW,. Medical management of advanced heart failure. JAMA 2002; 287: 628-640.
4. Jahns R, Boivin V, Siegmund C, Inselmann G, Lohse MJ, Boege F,. Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. Circulation 1999; 99: 649-654.
5. Limas CJ, Iakovis P, Anyfantakis A, Kroupis C, Cokkinos DV,. Familial clustering of autoimmune diseases in patients with dilated cardiomyopathy. Am J Cardiol 2004; 93: 1189-1191.
6. Limas CJ, Goldenberg IF, Limas C,. Autoantibodies against beta-1- adrenoceptors in human idiopathic dilated cardiomyopathy. Circ Res 1989; 64: 97-103.
7. Caforio AP, Tona F, Bottaro S, Vinci A, Dequal G, Daliento L, Thiene G, Iliceto S,. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy. J Heart Lung Transplant 2008; 41: 35-45.
8. Staudt A, Schäper F, Stangl V, Plagemann A, Böhm M, Merkel K, Wallukat G, Wernecke KD, Stangl K, Baumann G, Felix SB,. Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Circulation 2001; 103: 2681-2686.
9. Staudt A, Böhm M, Knebel F, Grosse Y, Bischoff C, Hummel A, Dahm JB, Borges A, Jochmann N, Wernecke KD, Wallukat G, Baumann G, Felix SB,. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy. Circulation 2002; 106: 2448-2453.
10. Staudt A, Staudt Y, Dörr M, Böhm M, Knebel F, Hummel A, Wunderle L, Tiburcy M, Wernecke KD, Baumann G, Felix SB,. Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy. J Am Coll Cardiol 2004; 44: 829-836.
11. Ameling S, Herda LR, Hammer E, Steil L, Teumer A, Trimpert C, Dörr M, Kroemer HK, Klingel K, Kandolf R, Völker U, Felix SB,. Myocardial gene expression profiles and cardiodepressant autoantibodies predict response of patients with dilated cardiomyopathy to immunoadsorption therapy. Eur Heart J 2013; 34: 666-675.
12. Dorffel WV, Felix SB, Wallukat G, Brehme S, Bestvater K, Hofmann T, Kleber FX, Baumann G, Reinke P,. Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy. Circulation 1997; 95: 1994-1997.
13. Knebel F, Böhm M, Staudt A, Borges AC, Tepper M, Jochmann N, Wernicke KD, Felix S, Baumann G,. Reduction of morbidity by immunoadsorption therapy in patients with dilated cardiomyopathy. Int J Cardiol 2004; 97: 517-520.
14. Dandel M, Wallukat G, Englert A, Lehmkuhl HB, Knosalla C, Hetzer R,. Long-term benefits of immunoadsorption in beta(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy. Eur J Heart Failure 2012; 14: 1374-1388.
15. Bulut D, Scheeler M, Wichmann T, Borgel J, Miebach T, Mugge A,. Effect of protein A immunoadsorption on T cell activation in patients with inflammatory dilated cardiomyopathy. Clin Res Cardiol 2010; 99: 633-638.
16. Bulut D, Scheeler M, Niedballa LM, Miebach T, Mugge A,. Effects of immunoadsorption on endothelial function, circulating endothelial progenitor cells and circulating microparticles in patients with inflammatory dilated cardiomyopathy. Clin Res Cardiol 2011; 100: 603-610.
17. Trimpert C, Herda LR, Eckerle LG, Pohle S, Müller C, Landsberger M, Felix SB, Staudt A,. Immunoadsorption in dilated cardiomyopathy: long-term reduction of cardiodepressant antibodies. Eur J Clin Invest 2010; 40: 685-691.
18. Staudt A, Hummel A, Ruppert J, Dörr M, Trimpert C, Birkenmeier K, Krieg T, Staudt Y, Felix SB,. Immunoadsorption in dilated cardiomyopathy: 6-month results from a randomized study. Am Heart J 2006; 152: 712.
19. Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, LeWinter MM, Deswal A, Rouleau JL, Ofili EO, Anstrom KJ, Hernandez AF, McNulty SE, Velazquez EJ, Kfoury AG, Chen HH, Givertz MM, Semigran MJ, Bart BA, Mascette AM, Braunwald E, O'Connor CM,. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 2011; 364: 797-805.
20. Cheitlin MD, Alpert JS, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davidson TW, Davis JL, Douglas PS, Gillam LD,. ACC/AHA guidelines for the clinical application of echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardiography. Circulation 1997; 95: 1686-1744.
21. Jones N,. Clinical exercise testing, 3rd ed. W. B. Saunders: Philadelphia; 1988. p 268.
22. Beaver WL, Wasserman K, Whipp BJ,. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 1986; 60: 2020-2027.
23. Bard RL, Gillespie BW, Clarke NS, Egan TG, Nicklas JM,. Determining the best ventilatory efficiency measure to predict mortality in patients with heart failure. J Heart Lung Transplant 2006; 25: 589-595.
24. Felix SB, Staudt A, Dorffel WV, Stangl V, Merkel K, Pohl M, Döcke WD, Morgera S, Neumayer HH, Wernecke KD, Wallukat G, Stangl K, Baumann G,. Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study. J Am Coll Cardiol 2000; 35: 1590-1598.
25. Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G, Vogelsberg H, Fritz P, Dippon J, Bock CT, Klingel K, Kandolf R, Sechtem U,. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 2006; 114: 1581-1590.
26. Schwartz J, Winters JL, Padmanabhan A, Balogun RA, Delaney M, Linenberger ML, Szczepiorkowski ZM, Williams ME, Wu Y, Shaz BH,. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the American Society for Apheresis: The Sixth Special Issue. J Clin Apheresis 2013; 28: 145-284.
27. Carr JG, Stevenson LW, Walden JA, Heber D,. Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1989; 63: 709-713.
28. Herda LR, Trimpert C, Nauke U, Landsberger M, Hummel A, Beug D, Kieback A, Dörr M, Empen K, Knebel F, Ewert R, Angelow A, Hoffmann W, Felix SB, Staudt A,. Effects of immunoadsorption and subsequent immunoglobulin G substitution on cardiopulmonary exercise capacity in patients with dilated cardiomyopathy. Am Heart J 2010; 159: 809-816.